Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Vaccine. 2009 Mar 10;27(11):1668-73. doi: 10.1016/j.vaccine.2009.01.035. Epub 2009 Feb 3.

Literature review of human papillomavirus vaccine acceptability among women over 26 years.

Author information

  • 1Department of Pediatrics, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555-0319, United States.

Abstract

Vaccines for the human papillomavirus (HPV) are currently licensed for females, ages 9 through 26 years old in the U.S., and for adult women up to 45 years in some countries such as Australia. As licensure for adult women, over 26 years, is sought in other countries, it will be important to determine the acceptability to them. We reviewed the available articles on adult opinions and acceptability of vaccinating women against HPV. Predictors of acceptability included barriers, knowledge, risk, age, and marital status. Overall, acceptability rates were high, if adequate information was given and the cost was affordable.

PMID:
19195491
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk